| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insmed Inc (INSM) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. INSM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 243.9K | $24.05M | - | |
| COO | 107.6K | $10.61M | - | |
| Other | 98.0K | $9.66M | - | |
| Other | 84.9K | $8.37M | - | |
| CEO | 81.4K | $8.02M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2024 | Bonstein Sara | Chief Financial Officer | Sell | 11,088 | $25.32 | $280,748.16 | -8.6% | +191.1% | +157.8% | |
| May 14, 2024 | Adsett Roger | Chief Operating Officer | Sell | 7,857 | $25.50 | $200,353.50 | -4.8% | +191.1% | +157.8% | |
| May 14, 2024 | Flammer Martina M.D. | Chief Medical Officer | Sell | 10,640 | $25.47 | $271,000.80 | -8.8% | +191.1% | +157.8% | |
| May 14, 2024 | Wise John Drayton | Chief Commercial Officer | Sell | 5,088 | $25.47 | $129,591.36 | -4.0% | +191.1% | +157.8% | |
| Jan 12, 2024 | Flammer Martina M.D. | Chief Medical Officer | Sell | 4,667 | $28.63 | $133,616.21 | -4.2% | +0.4% | +129.3% | |
| Jan 12, 2024 | Adsett Roger | Chief Operating Officer | Sell | 5,251 | $28.63 | $150,336.13 | -3.4% | +0.4% | +129.3% | |
| Jan 10, 2024 | Flammer Martina M.D. | Chief Medical Officer | Sell | 5,960 | $28.99 | $172,762.65 | -2.6% | -1.2% | +130.2% | |
| Jan 10, 2024 | Adsett Roger | Chief Operating Officer | Sell | 7,373 | $29.08 | $214,422.65 | -2.3% | -1.2% | +130.2% | |
| Jan 9, 2024 | Smith Michael Alexander | General Counsel, Senior VP | Sell | 2,373 | $28.76 | $68,247.48 | -2.7% | -3.4% | +125.8% | |
| Jan 9, 2024 | Wise John Drayton | Chief Commercial Officer | Sell | 1,861 | $28.78 | $53,559.58 | -1.6% | -3.4% | +125.8% |